Advertisement

Topics

Turning Point Therapeutics, Inc. Company Profile

11:59 EDT 21st March 2019 | BioPortfolio

Turning Point Therapeutics is a clinical-stage precision oncology company forging a new path for targeted cancer care. Founded in October 2013 by Dr. J. Jean Cui, the lead inventor of Pfizer’s oncology drugs crizotinib and lorlatinib, the company is developing a pipeline of novel drugs that aim to tackle treatment resistance and give new hope to patients who have stopped responding to available targeted therapies. Mounting clinical data for the company’s lead program, repotrectinib, a next-generation kinase inhibitor targeting genetic drivers of non-small cell lung cancer and advanced solid tumors, has shown ongoing antitumor activity and durable responses among treatment-naïve and pre-treated patients. With additional programs underway to address similarly intractable oncogenic drivers, Turning Point Therapeutics is marking a turning point in the way solid-tumor cancers are treated. For more information, visit www.tptherapeutics.com.


News Articles [1231 Associated News Articles listed on BioPortfolio]

The Economics Of Cures - Gilead At A Turning Point

FMT for ulcerative colitis: closer to the turning point

Turning Point Therapeutics Appoints Dr. Robert Xin as Senior Vice President of Clinical Development

Turning Point Therapeutics, Inc., a clinical-stage precision oncology company developing novel drugs that address treatment resistance, today announced the appointment of Robert (...

BioCryst Has An Expected Turning Point In 2019 That Could Shift Momentum

Nursing Leaders: Mandate Recommended Shots

This could be a turning point in the controversy over healthcare immunizations.

ICYMI: Just days before #MidtermElections2018, Ken Frazier spoke to @andrewrsorkin during #Dealbook about businesses reaching a turning point in today’s society. Read the full recap here: https://nyti.ms/2SPHkDR 

ICYMI: Just days before #MidtermElections2018, Ken Frazier spoke to @andrewrsorkin during #Dealbook about businesses reaching a turning point in today’s society. Read the full recap here: ht...

Turning Point Therapeutics Appoints Jacob Chacko, M.D., to its Board of Directors

Turning Point Therapeutics, Inc. (TP Therapeutics), a clinical-stage precision oncology company developing novel drugs that address treatment resistance, today announced the appoi...

Any minute, a powerful story will be told @thehamiltondc during a screening of “The Turning Point.” Thanks to @AtlanticLIVE for partnering with us to tell this story of innovation & a commitment to patients in the search for an Alzheimer's cure. #GoBo

Any minute, a powerful story will be told @thehamiltondc during a screening of “The Turning Point.” Thanks to @AtlanticLIVE for partnering with us to tell this story of innovation & ...

PubMed Articles [1020 Associated PubMed Articles listed on BioPortfolio]

Impact of behavioral change on the epidemic characteristics of an epidemic model without vital dynamics.

The epidemic characteristics of an epidemic model with behavioral change in [V. Capasso, G. Serio, A generalizaition of the Kermack-McKendrick deterministic epidemic model, Math. Bios., 42 (1978), 43-...

Turning Stability in Individuals With Parkinson Disease.

Although instability during turning is a disabling feature of Parkinson disease (PD), little is known about the associated postural characteristics. Our goals were to compare turning stability between...

A Turning Point in Typhoid Control.

FMT for ulcerative colitis: closer to the turning point.

CO laser-written long-period fiber grating with a high diffractive order cladding mode near the turning point.

We demonstrate the fabrication of a long-period fiber grating (LPFG) in a boron-doped single-mode fiber with a high-diffractive-order cladding mode (HDCM) near the turning point (TP). The simulations ...

Clinical Trials [1511 Associated Clinical Trials listed on BioPortfolio]

Effectivity and Efficiency of Turning Frequencies: a Randomised Controlled Trial

Evaluation of the difference in pressure ulcer incidence or the time to develop pressure ulcers depending on the turning frequencies.

Pilot Study of Lateral Rotation Interventions for Efficacy and Safety in ICU Care

Intensive care unit (ICU) patients on respirators are at high risk for preventable pulmonary complications (PPC). Turning these patients from side to side may reduce PPC, but carries the b...

Optimal Patient Turning for Reducing Hospital Acquired Pressure Ulcers

The purpose of this study is to test whether optimal patient turning, strictly every 2 hours with at least 15 minutes of tissue decompression, reduces the occurrence of hospital acquired p...

The Validity and Reliability of a Wearable System for Assessing Turning Characteristics.

The Validity and Reliability of a Wearable System for Assessing Turning Characteristics.

Pressure Ulcer Prevention: Turning for Ulcer Reduction

The purpose of the study is to determine the optimal frequency of repositioning nursing facility residents with limited mobility who are cared for on a high density foam mattress in order ...

Companies [1858 Associated Companies listed on BioPortfolio]

Turning Point Therapeutics, Inc.

Turning Point Therapeutics is a clinical-stage precision oncology company forging a new path for targeted cancer care. Founded in October 2013 by Dr. J. Jean Cui, the lead invento...

Turning Point

Based in Toledo, Ohio, Turning Point focuses on bringing to market bioengineering advancements that optimize human performance more accurately and quickly. Designed by bioengineer...

Turning Point Therapeutics Inc.

TP Therapeutics Inc.

TP Therapeutics is a clinical-stage precision oncology company forging a new path for targeted cancer care. Founded in October 2013 by Dr. J. Jean Cui, the lead inventor of Pfizer...

Point Therapeutics

Point Therapeutics, Inc is a Boston-based biopharmaceutical company dedicated to developing a family of dipeptidyl peptidase (DPP) inhibitors for use in cancer, type 2 diabetes and as vaccine adjuvan...

More Information about "Turning Point Therapeutics, Inc." on BioPortfolio

We have published hundreds of Turning Point Therapeutics, Inc. news stories on BioPortfolio along with dozens of Turning Point Therapeutics, Inc. Clinical Trials and PubMed Articles about Turning Point Therapeutics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Turning Point Therapeutics, Inc. Companies in our database. You can also find out about relevant Turning Point Therapeutics, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record